The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Gut health food brand Bio&Me, created by The Gut Health Doctor, has secured a £1.6 million investment to support further growth. A portion of the funds will be used for marketing to drive the brand's growth. The capital will also support the expansion of Bio&Me's sales team and the launch of its next innovation. Bio&Me started out selling granolas in November 2019 and has since expanded its range to include porridges and live yogurts – all containing the prebiotic, chicory inulin. Co-founder and CEO, Jon Walsh, commented: “The fact our revenue has more than doubled year-on-year made it a great time for us to do our raise. Bio&Me is now in a really strong position to continue its growth rate across 2023, driven by consumer demand for products that taste good as well as do good. We’re looking ahead to our next big gut health category launch next year – watch this space.” FMCG entrepreneur and lead investor in Bio&Me, Giles Brook, said: “Collectively, the team has done a fantastic job raising our funding target in such a short timeframe, with 70% of those funds coming from existing investors, showing the degree of confidence they have in the business, brand and team”. Brook continued: “With a significant amount of incremental business already secured for 2023, we believe it's set to be another landmark year with even more consumers coming on board and adopting Bio&Me’s great-tasting, gut-healthy products into their daily lives”. Megan Rossi, Bio&Me co-founder, said: “I am so grateful to our current and new investors for believing in us and our mission. My goal has always been to make tasty food solutions that can carry genuine health claims. As a dietitian and scientist, that is what matters to me, and I believe is what is driving Bio&Me’s growth.”